NovoRapid PumpCart is to be marketed in Europe. The 1.6 ml prefilled insulin pump cartridge contains the rapid-acting NovoRapid insulin and is compatible with Roche Diabetes Care’s next-generation Accu-Chek Insight diabetes therapy system.
NovoRapid PumpCart has been developed in a non-exclusive partnership between Roche Diabetes Care, a pioneer and global market leader in the development of diabetes management solutions and services, and Novo Nordisk, a world leader in diabetes care. The prefilled cartridge and insulin delivery system should make insulin pump therapy more convenient as it means you do longer need to fill up insulin reservoirs from insulin bottles.
“Now, insulin pump users can simply place a prefilled insulin cartridge into their insulin pump without any extra handling steps. Novo Nordisk is committed to improving diabetes care, so we are pleased to provide pump users with this new treatment option”, says Jakob Riis, executive vice president, Marketing and Medical Affairs, Novo Nordisk.
Luc Vierstraete, Global Head of Roche Diabetes Care, adds: “We are excited to be able to offer this solution to our customers and bring to market our innovative Accu-Chek Insight diabetes therapy system compatible with the option of using the new prefilled insulin cartridge. This can help to enhance the advantages of a targeted and effective insulin pump therapy while contributing to a simplified diabetes management in everyday life.”
NovoRapid PumpCart will be launched in selected European countries during 2014 and 2015.